Literature DB >> 25351853

The key role of transient receptor potential melastatin-2 channels in amyloid-β-induced neurovascular dysfunction.

L Park1, G Wang1, J Moore1, H Girouard1, P Zhou1, J Anrather1, C Iadecola1.   

Abstract

Alzheimer's dementia is a devastating and incurable disease afflicting over 35 million people worldwide. Amyloid-β (Aβ), a key pathogenic factor in this disease, has potent cerebrovascular effects that contribute to brain dysfunction underlying dementia by limiting the delivery of oxygen and glucose to the working brain. However, the downstream pathways responsible for the vascular alterations remain unclear. Here we report that the cerebrovascular dysfunction induced by Aβ is mediated by DNA damage caused by vascular oxidative-nitrosative stress in cerebral endothelial cells, which, in turn, activates the DNA repair enzyme poly(ADP)-ribose polymerase. The resulting increase in ADP ribose opens transient receptor potential melastatin-2 (TRPM2) channels in endothelial cells leading to intracellular Ca(2+) overload and endothelial dysfunction. The findings provide evidence for a previously unrecognized mechanism by which Aβ impairs neurovascular regulation and suggest that TRPM2 channels are a potential therapeutic target to counteract cerebrovascular dysfunction in Alzheimer's dementia and related pathologies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25351853      PMCID: PMC4283829          DOI: 10.1038/ncomms6318

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  69 in total

1.  Accumulation of free ADP-ribose from mitochondria mediates oxidative stress-induced gating of TRPM2 cation channels.

Authors:  Anne-Laure Perraud; Christina L Takanishi; Betty Shen; Shin Kang; Megan K Smith; Carsten Schmitz; Heather M Knowles; Dana Ferraris; Weixing Li; Jie Zhang; Barry L Stoddard; Andrew M Scharenberg
Journal:  J Biol Chem       Date:  2004-11-23       Impact factor: 5.157

Review 2.  The blood-brain barrier in health and chronic neurodegenerative disorders.

Authors:  Berislav V Zlokovic
Journal:  Neuron       Date:  2008-01-24       Impact factor: 17.173

3.  Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy.

Authors:  Andrew Dumas; Gregory A Dierksen; M Edip Gurol; Amy Halpin; Sergi Martinez-Ramirez; Kristin Schwab; Jonathan Rosand; Anand Viswanathan; David H Salat; Jonathan R Polimeni; Steven M Greenberg
Journal:  Ann Neurol       Date:  2012-07       Impact factor: 10.422

Review 4.  TRPM2.

Authors:  J Eisfeld; A Lückhoff
Journal:  Handb Exp Pharmacol       Date:  2007

5.  Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation.

Authors:  L Virág; P Jagtap; E Szabó; J G Mabley; L Liaudet; A Marton; D G Hoyt; K G Murthy; A L Salzman; G J Southan; C Szabó
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

6.  Exogenous A beta1-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice.

Authors:  K Niwa; G A Carlson; C Iadecola
Journal:  J Cereb Blood Flow Metab       Date:  2000-12       Impact factor: 6.200

7.  Hydrogen peroxide and ADP-ribose induce TRPM2-mediated calcium influx and cation currents in microglia.

Authors:  Robert Kraft; Christian Grimm; Karin Grosse; Anja Hoffmann; Sophie Sauerbruch; Helmut Kettenmann; Günter Schultz; Christian Harteneck
Journal:  Am J Physiol Cell Physiol       Date:  2003-09-24       Impact factor: 4.249

8.  Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein.

Authors:  Laibaik Park; Ping Zhou; Rose Pitstick; Carmen Capone; Josef Anrather; Erin H Norris; Linda Younkin; Steven Younkin; George Carlson; Bruce S McEwen; Costantino Iadecola
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-17       Impact factor: 11.205

9.  Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease.

Authors:  Z Q Wang; B Auer; L Stingl; H Berghammer; D Haidacher; M Schweiger; E F Wagner
Journal:  Genes Dev       Date:  1995-03-01       Impact factor: 11.361

10.  Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease.

Authors:  Alex E Roher; Chera L Esh; Tyler A Kokjohn; Eduardo M Castaño; Gregory D Van Vickle; Walter M Kalback; R Lyle Patton; Dean C Luehrs; Ian D Daugs; Yu-Min Kuo; Mark R Emmerling; Holly Soares; Joseph F Quinn; Jeffrey Kaye; Donald J Connor; Nina B Silverberg; Charles H Adler; James D Seward; Thomas G Beach; Marwan N Sabbagh
Journal:  Alzheimers Dement       Date:  2009-01       Impact factor: 21.566

View more
  57 in total

1.  Neuronal expression of the mitochondrial protein prohibitin confers profound neuroprotection in a mouse model of focal cerebral ischemia.

Authors:  Anja Kahl; Corey J Anderson; Liping Qian; Henning Voss; Giovanni Manfredi; Costantino Iadecola; Ping Zhou
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-17       Impact factor: 6.200

Review 2.  Transient Receptor Potential Channels and Endothelial Cell Calcium Signaling.

Authors:  Pratish Thakore; Scott Earley
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

Review 3.  Preventing dementia by preventing stroke: The Berlin Manifesto.

Authors:  Vladimir Hachinski; Karl Einhäupl; Detlev Ganten; Suvarna Alladi; Carol Brayne; Blossom C M Stephan; Melanie D Sweeney; Berislav Zlokovic; Yasser Iturria-Medina; Costantino Iadecola; Nozomi Nishimura; Chris B Schaffer; Shawn N Whitehead; Sandra E Black; Leif Østergaard; Joanna Wardlaw; Steven Greenberg; Leif Friberg; Bo Norrving; Brian Rowe; Yves Joanette; Werner Hacke; Lewis Kuller; Martin Dichgans; Matthias Endres; Zaven S Khachaturian
Journal:  Alzheimers Dement       Date:  2019-07       Impact factor: 21.566

Review 4.  Neurovascular and Cognitive Dysfunction in Hypertension.

Authors:  Costantino Iadecola; Rebecca F Gottesman
Journal:  Circ Res       Date:  2019-03-29       Impact factor: 17.367

Review 5.  Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium.

Authors:  Livius V d'Uscio; Tongrong He; Zvonimir S Katusic
Journal:  Physiology (Bethesda)       Date:  2017-01

Review 6.  Microvascular Dysfunction and Cognitive Impairment.

Authors:  T Michael De Silva; Frank M Faraci
Journal:  Cell Mol Neurobiol       Date:  2016-03-17       Impact factor: 5.046

Review 7.  The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease.

Authors:  Costantino Iadecola
Journal:  Neuron       Date:  2017-09-27       Impact factor: 17.173

Review 8.  Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.

Authors:  Kassandra Kisler; Amy R Nelson; Axel Montagne; Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

9.  Brain Perivascular Macrophages Initiate the Neurovascular Dysfunction of Alzheimer Aβ Peptides.

Authors:  Laibaik Park; Ken Uekawa; Lidia Garcia-Bonilla; Kenzo Koizumi; Michelle Murphy; Rose Pistik; Linda Younkin; Steven Younkin; Ping Zhou; George Carlson; Josef Anrather; Costantino Iadecola
Journal:  Circ Res       Date:  2017-05-17       Impact factor: 17.367

Review 10.  Endothelial Dysfunction and Amyloid-β-Induced Neurovascular Alterations.

Authors:  Kenzo Koizumi; Gang Wang; Laibaik Park
Journal:  Cell Mol Neurobiol       Date:  2015-09-02       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.